Process View
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cellular response to interferon gamma"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.983 | Human | |
| STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.966 | ||
| JAK2 | Janus kinase 2 | 0.896 | Rat | |
| RXRA | retinoid X receptor, alpha | 0.861 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.849 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.762 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.753 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.730 | Human | |
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.626 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.542 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.537 | ||
| INSR | insulin receptor | 0.460 | ||
| IRF9 | interferon regulatory factor 9 | 0.442 | ||
| HCK | hemopoietic cell kinase | 0.441 | Human | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.407 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.400 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.398 | ||
| STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.379 | Human | |
| NCK1 | NCK adaptor protein 1 | 0.370 | ||
| GHR | growth hormone receptor | 0.357 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.347 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.314 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.312 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.282 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.279 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.275 | Human | |
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.258 | ||
| GBP4 | guanylate binding protein 4 | 0.257 | Mouse | |
| BIRC3 | baculoviral IAP repeat containing 3 | 0.247 | ||
| EGFR | epidermal growth factor receptor | 0.244 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.213 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.200 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.187 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.171 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.166 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.163 | ||
| ITK | IL2-inducible T-cell kinase | 0.154 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.146 | ||
| IFNGR1 | interferon gamma receptor 1 | 0.145 | ||
| PRMT6 | protein arginine methyltransferase 6 | 0.145 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.135 | ||
| PDCD6 | programmed cell death 6 | 0.133 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.131 | Human | |
| PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.129 | ||
| GBP1 | guanylate binding protein 1, interferon-inducible | 0.126 | ||
| IDE | insulin-degrading enzyme | 0.124 | ||
| IL2RB | interleukin 2 receptor, beta | 0.113 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.107 | ||
| JAK1 | Janus kinase 1 | 0.106 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.103 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.097 | ||
| MED28 | mediator complex subunit 28 | 0.090 | ||
| GBP2 | guanylate binding protein 2, interferon-inducible | 0.090 | Mouse | |
| C3 | complement component 3 | 0.087 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.085 | ||
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.081 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.080 | Human | |
| SOCS3 | suppressor of cytokine signaling 3 | 0.079 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.078 | Human | |
| IRF1 | interferon regulatory factor 1 | 0.078 | Mouse | |
| CCR7 | chemokine (C-C motif) receptor 7 | 0.077 | ||
| IL12RB2 | interleukin 12 receptor, beta 2 | 0.072 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.072 | Human | |
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.068 | ||
| GAS7 | growth arrest-specific 7 | 0.065 | ||
| GDF9 | growth differentiation factor 9 | 0.060 | ||
| IL1B | interleukin 1, beta | 0.057 | ||
| CFHR1 | complement factor H-related 1 | 0.056 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.056 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.053 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.053 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.052 | ||
| IL8 | interleukin 8 | 0.052 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.051 | ||
| SPRR2A | small proline-rich protein 2A | 0.050 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.048 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.047 | Human | |
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.046 | Human | |
| SLA | Src-like-adaptor | 0.045 | ||
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.045 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.045 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.045 | ||
| STAP2 | signal transducing adaptor family member 2 | 0.044 | ||
| HSP90AB1 | heat shock protein 90kDa alpha (cytosolic), class B member 1 | 0.044 | ||
| IFNG | interferon, gamma | 0.043 | ||
| DHX9 | DEAH (Asp-Glu-Ala-His) box polypeptide 9 | 0.042 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.042 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.042 | Human | |
| NMI | N-myc (and STAT) interactor | 0.042 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.041 | ||
| KLHL20 | kelch-like 20 (Drosophila) | 0.041 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.040 | Human | |
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.040 | ||
| TNF | tumor necrosis factor | 0.039 | ||
| IRS1 | insulin receptor substrate 1 | 0.039 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.038 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.037 | ||
| IL15 | interleukin 15 | 0.036 | ||
| BTN3A1 | butyrophilin, subfamily 3, member A1 | 0.036 | ||
| UBD | ubiquitin D | 0.036 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.035 | ||
| ARRB1 | arrestin, beta 1 | 0.034 | ||
| CD83 | CD83 molecule | 0.034 | ||
| IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0.033 | ||
| IFNAR1 | interferon (alpha, beta and omega) receptor 1 | 0.033 | ||
| MAVS | mitochondrial antiviral signaling protein | 0.032 | ||
| HLA-B | major histocompatibility complex, class I, B | 0.032 | ||
| APOL3 | apolipoprotein L, 3 | 0.032 | ||
| HLA-F | major histocompatibility complex, class I, F | 0.031 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.030 | ||
| HLA-E | major histocompatibility complex, class I, E | 0.029 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.029 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.029 | ||
| TAPBP | TAP binding protein (tapasin) | 0.029 | ||
| HCP5 | HLA complex P5 | 0.028 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.027 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.026 | ||
| OFCC1 | orofacial cleft 1 candidate 1 | 0.026 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.026 | ||
| ANG | angiogenin, ribonuclease, RNase A family, 5 | 0.025 | ||
| COMMD1 | copper metabolism (Murr1) domain containing 1 | 0.025 | ||
| HR | hairless homolog (mouse) | 0.025 | ||
| UBA52 | ubiquitin A-52 residue ribosomal protein fusion product 1 | 0.025 | ||
| TNFAIP8 | tumor necrosis factor, alpha-induced protein 8 | 0.024 | ||
| FUS | fused in sarcoma | 0.024 | ||
| CDK8 | cyclin-dependent kinase 8 | 0.024 | ||
| HLA-A | major histocompatibility complex, class I, A | 0.024 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.024 | ||
| SERPINB9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 | 0.024 | ||
| IRF4 | interferon regulatory factor 4 | 0.023 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.023 | Human | |
| ESR2 | estrogen receptor 2 (ER beta) | 0.023 | ||
| PRMT1 | protein arginine methyltransferase 1 | 0.023 | ||
| PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.022 | ||
| PML | promyelocytic leukemia | 0.022 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.022 | Zebrafish | |
| RBMX | RNA binding motif protein, X-linked | 0.022 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.022 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.021 | ||
| SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | 0.020 | ||
| ESRRG | estrogen-related receptor gamma | 0.020 | ||
| GBP5 | guanylate binding protein 5 | 0.020 | Mouse | |
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.020 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.020 | ||
| EHD1 | EH-domain containing 1 | 0.019 | ||
| SLAMF8 | SLAM family member 8 | 0.019 | ||
| HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | 0.019 | ||
| CTSS | cathepsin S | 0.019 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.019 | ||
| TOP1 | topoisomerase (DNA) I | 0.019 | ||
| NRG1 | neuregulin 1 | 0.019 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.019 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.018 | Human | |
| IL10 | interleukin 10 | 0.018 | ||
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.018 | ||
| SASH3 | SAM and SH3 domain containing 3 | 0.018 | ||
| CD163 | CD163 molecule | 0.018 | ||
| CCND3 | cyclin D3 | 0.018 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.018 | ||
| PGR | progesterone receptor | 0.018 | ||
| JAK3 | Janus kinase 3 | 0.018 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.018 | ||
| FYB | FYN binding protein | 0.017 | ||
| TGS1 | trimethylguanosine synthase 1 | 0.017 | ||
| IFI16 | interferon, gamma-inducible protein 16 | 0.017 | ||
| MPEG1 | macrophage expressed 1 | 0.017 | ||
| FPR3 | formyl peptide receptor 3 | 0.017 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.017 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.017 | ||
| IRF8 | interferon regulatory factor 8 | 0.017 | ||
| SNX33 | sorting nexin 33 | 0.016 | ||
| SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 0.016 | ||
| IFIH1 | interferon induced with helicase C domain 1 | 0.016 | ||
| SELE | selectin E | 0.015 | ||
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.015 | ||
| MVP | major vault protein | 0.015 | ||
| CCL17 | chemokine (C-C motif) ligand 17 | 0.015 | Human | |
| EBI3 | Epstein-Barr virus induced 3 | 0.015 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.015 | Mouse | |
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.015 | ||
| C1S | complement component 1, s subcomponent | 0.015 | ||
| BCL2A1 | BCL2-related protein A1 | 0.014 | ||
| CHORDC1 | cysteine and histidine-rich domain (CHORD) containing 1 | 0.014 | ||
| DARC | Duffy blood group, chemokine receptor | 0.014 | ||
| IARS | isoleucyl-tRNA synthetase | 0.014 | ||
| HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 0.014 | Human | |
| FAS | Fas (TNF receptor superfamily, member 6) | 0.014 | ||
| ITGA1 | integrin, alpha 1 | 0.013 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.013 | ||
| CAPN1 | calpain 1, (mu/I) large subunit | 0.013 | ||
| IL7R | interleukin 7 receptor | 0.013 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.013 | ||
| RUNX1 | runt-related transcription factor 1 | 0.013 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.013 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.013 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.013 | ||
| RUNX3 | runt-related transcription factor 3 | 0.013 | ||
| PKM2 | pyruvate kinase, muscle | 0.013 | ||
| NR1I2 | nuclear receptor subfamily 1, group I, member 2 | 0.013 | Human | |
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.013 | ||
| ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.013 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.012 | ||
| CD86 | CD86 molecule | 0.012 | ||
| HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 | 0.012 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.012 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.012 | ||
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.012 | ||
| ARPC3 | actin related protein 2/3 complex, subunit 3, 21kDa | 0.012 | ||
| PARP9 | poly (ADP-ribose) polymerase family, member 9 | 0.012 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.012 | ||
| NBN | nibrin | 0.012 | ||
| B2M | beta-2-microglobulin | 0.012 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.012 | ||
| MTDH | metadherin | 0.012 | ||
| TNS3 | tensin 3 | 0.012 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.011 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.011 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.011 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.011 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.011 | ||
| SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | 0.011 | ||
| KYNU | kynureninase | 0.011 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.011 | ||
| AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 | 0.011 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.011 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.011 | Human | |
| MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.011 | ||
| LITAF | lipopolysaccharide-induced TNF factor | 0.011 | ||
| HNRNPA0 | heterogeneous nuclear ribonucleoprotein A0 | 0.011 | ||
| IL18BP | interleukin 18 binding protein | 0.011 | ||
| HDAC3 | histone deacetylase 3 | 0.011 | ||
| EEF1G | eukaryotic translation elongation factor 1 gamma | 0.011 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.011 | ||
| CH25H | cholesterol 25-hydroxylase | 0.011 | ||
| SP1 | Sp1 transcription factor | 0.011 | ||
| APOL6 | apolipoprotein L, 6 | 0.011 | ||
| CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.011 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.011 | Human | |
| MUC1 | mucin 1, cell surface associated | 0.011 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.011 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.011 | ||
| IL21R | interleukin 21 receptor | 0.011 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.010 | ||
| APOL1 | apolipoprotein L, 1 | 0.010 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.010 | ||
| RPL3 | ribosomal protein L3 | 0.010 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.010 | ||
| LARS | leucyl-tRNA synthetase | 0.010 | ||
| YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | 0.010 | Human | |
| HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 | 0.010 | ||
| ZNFX1 | zinc finger, NFX1-type containing 1 | 0.010 | ||
| APOC1 | apolipoprotein C-I | 0.010 | ||
| IRF2 | interferon regulatory factor 2 | 0.010 |